ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.918,01
0,04%
S&P 500
5.881,63
-0,43%
Dow Jones
42.544,22
0,00%
Euro vs US Dollar
1,03169
-0,33%
Bitcoin
96.620,30
2,37%
Pepperstone
Advertisement
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. TC BioPharm Holdings PLC (TCBP) Börsenkurse

TC BioPharm Holdings PLC

TC BioPharm Holdings PLC (TCBP)

NASDAQ
0,645
0,037
(6,09%)
Geschlossen 01 Januar 10:00PM
Verzögert um 15 Minuten
0,6899
0,1739
( 33,70% )
Vor Marktöffnung: 2:00PM
Verzögert um 15 Minuten

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
0,6899
Gebot
0,6899
Fragen
0,70
Volumen
121.651
0,00 Tagesbereich 0,00
0,00 52-Wochen-Bereich 0,00
Marktkapitalisierung
401,536k
Handelsende
0,516
Handelsbeginn
-
Letzte Trade
22
@
0.7
Letzter Handelszeitpunkt
14:00:26
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
-
Ausgegebene Aktien
582.020
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,05
Gewinn pro Aktie (EPS)
-10,15
Erlöse
-
Nettogewinn
-5,91M

Über TC BioPharm Holdings PLC

TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform.

Sektor
Coml Physical, Biologcl Resh
Branche
Coml Physical, Biologcl Resh
Website
www.tcbiopharm.com
Hauptsitz
Scotland, Gbr
Gegründet
-
TC BioPharm Holdings PLC is listed in the Coml Physical, Biologcl Resh sector of the NASDAQ with ticker TCBP. The last closing price for TC BioPharm was US$0,52. Over the last year, TC BioPharm shares have traded in a share price range of US$ 0,00 to US$ 0,00.

TC BioPharm currently has 582.020 shares in issue. The market capitalisation of TC BioPharm is US$300.322,32 . TC BioPharm has a price to earnings ratio (PE ratio) of -0.05.

TCBP Neueste Nachrichten

Weitere Nachrichten

TCBP Provides Update on Acquisition Strategy and Current Targets

TCBP Provides Update on Acquisition Strategy and Current Targets PR Newswire EDINBURGH, Scotland, Dec. 31, 2024 EDINBURGH, Scotland, Dec. 31, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC...

31 Dezember 2024
PR Newswire (US)

TCBP Issues 25% Stock Dividend

TCBP Issues 25% Stock Dividend PR Newswire EDINBURGH, Scotland, Dec. 30, 2024 EDINBURGH, Scotland, Dec. 30, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company...

30 Dezember 2024
PR Newswire (US)

TCBP Advances ACHIEVE Phase 2b Clinical Trial with Final Dosing of 3 Patients

TCBP Advances ACHIEVE Phase 2b Clinical Trial with Final Dosing of 3 Patients PR Newswire EDINBURGH, Scotland, Dec. 20, 2024 EDINBURGH, Scotland, Dec. 20, 2024 /PRNewswire/ -- TC BioPharm...

20 Dezember 2024
PR Newswire (US)

TCBP Announces General Meeting of Shareholders to Approve One-Time Shareholder Dividend

TCBP Announces General Meeting of Shareholders to Approve One-Time Shareholder Dividend PR Newswire EDINBURGH, Scotland, Dec. 18, 2024 EDINBURGH, Scotland, Dec. 18, 2024 /PRNewswire/ -- TC...

18 Dezember 2024
PR Newswire (US)

TCBP Partners with CareDx to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy

TCBP Partners with CareDx to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy PR Newswire EDINBURGH, Scotland, Dec. 11, 2024 EDINBURGH...

11 Dezember 2024
PR Newswire (US)

TCBP Provides Quarterly Update on the ACHIEVE (UK) Clinical Trial

TCBP Provides Quarterly Update on the ACHIEVE (UK) Clinical Trial PR Newswire EDINBURGH, Scotland, Dec. 4, 2024 Positive safety data, allowing for exploration of higher TCB008 doses4 UK-based...

04 Dezember 2024
PR Newswire (US)

TCBP Awarded Non-Dilutive Funding, ScaleReady's G-Rex® Grant

TCBP Awarded Non-Dilutive Funding, ScaleReady's G-Rex® Grant PR Newswire EDINBURGH, Scotland, Nov. 12, 2024 EDINBURGH, Scotland, Nov. 12, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC...

12 November 2024
PR Newswire (US)

TCBP Provides Shareholder Update and Highlights Recent Milestone Achievements

TCBP Provides Shareholder Update and Highlights Recent Milestone Achievements PR Newswire EDINBURGH, Scotland, Oct. 30, 2024 EDINBURGH, Scotland, Oct. 30, 2024 /PRNewswire/ -- TC BioPharm...

30 Oktober 2024
PR Newswire (US)

TCBP Responds to False Social Media Claim

TCBP Responds to False Social Media Claim PR Newswire EDINBURGH, Scotland, Oct. 25, 2024 TC BioPharm remains compliant with all Nasdaq listing requirements and will continue trading on the...

25 Oktober 2024
PR Newswire (US)

TCBP Enters Research Planning Collaboration with Dr. Carlos Maluquer de Motes for Mpox Therapeutic

TCBP Enters Research Planning Collaboration with Dr. Carlos Maluquer de Motes for Mpox Therapeutic PR Newswire EDINBURGH, Scotland, Oct. 22, 2024 EDINBURGH, Scotland, Oct. 22, 2024 /PRNewswire/...

22 Oktober 2024
PR Newswire (US)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

TCBP - Frequently Asked Questions (FAQ)

What is the current TC BioPharm share price?
The current share price of TC BioPharm is US$ 0,6899
How many TC BioPharm shares are in issue?
TC BioPharm has 582.020 shares in issue
What is the market cap of TC BioPharm?
The market capitalisation of TC BioPharm is USD 300,32k
What is the 1 year trading range for TC BioPharm share price?
TC BioPharm has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the PE ratio of TC BioPharm?
The price to earnings ratio of TC BioPharm is -0,05
What is the reporting currency for TC BioPharm?
TC BioPharm reports financial results in GBP
What is the latest annual profit for TC BioPharm?
The latest annual profit of TC BioPharm is GBP -5,91M
What is the registered address of TC BioPharm?
The registered address for TC BioPharm is MAXIM 1, 2 PARKLANDS WAY, HOLYTOWN, SCOTLAND, ML1 4WR
What is the TC BioPharm website address?
The website address for TC BioPharm is www.tcbiopharm.com
Which industry sector does TC BioPharm operate in?
TC BioPharm operates in the COML PHYSICAL, BIOLOGCL RESH sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
RAINRain Enhancement Technologies Holdco Inc
 11,39
(841,32%)
260
REVBRevelation Biosciences Inc
US$ 1,12
(142,95%)
30,02M
CGBSCrown LNG Holdings Ltd
US$ 0,9629
(140,66%)
43,73M
TOIIWOncology Institute Inc
US$ 0,0123
(136,54%)
4,47k
AEIAlset Inc
US$ 2,10
(105,88%)
15,56M
NMRANeumora Therapeutics Inc
US$ 1,90
(-82,08%)
882,43k
BDMDBaird Medical Investment Holdings Ltd
US$ 4,82
(-36,58%)
336,99k
SIDUSidus Space Inc
US$ 3,21
(-34,49%)
2,07M
AIPArteris Inc
US$ 8,01
(-21,39%)
51
MARXMars Acquisition Corporation
US$ 7,35
(-21,39%)
46,53k
CMCTCreative Media and Community Trust Corporation
US$ 0,3025
(34,44%)
44,92M
CGBSCrown LNG Holdings Ltd
US$ 0,9629
(140,66%)
43,73M
SVMHSRIVARU Holding Ltd
US$ 0,0463
(9,98%)
35,41M
REVBRevelation Biosciences Inc
US$ 1,12
(142,95%)
30,02M
ALCEAlternus Clean Energy Inc
US$ 1,60
(103,61%)
20,78M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
TCBP
TC BioPharm
BIT
NSCIT1574150
Pfizer
BIT
WNUS24
Nusco
BIT
1BLK
Blackrock
BIT
NSCIT81X0CM6
InterAmerican Developmen...
BIT
F06718
Vontobel Financial Produ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten